HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$890M |
| 2 |
Apple
AAPL
|
+$842M |
| 3 |
Microsoft
MSFT
|
+$360M |
| 4 |
Equitable Holdings
EQH
|
+$212M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$129M |
| 2 |
Citigroup
C
|
+$103M |
| 3 |
Elevance Health
ELV
|
+$93.4M |
| 4 |
Arch Capital
ACGL
|
+$90.7M |
| 5 |
Crown Holdings
CCK
|
+$90M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.74% |
| 3 | Healthcare | 11.23% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Regenxbio
RGNX
$620M
| $504K | ﹤0.01% |
28,145
-2,437
| -8% | -$42.9K |
|
2052
Progress Software
PRGS
$1.66B
| $498K | ﹤0.01% |
9,189
-2,654
| -22% | -$141K |
|
2053
BrightView Holdings
BV
$1.22B
| $498K | ﹤0.01% |
58,784
+4,057
| +7% | +$30.9K |
|
2054
PUT
iQIYI
IQ
$1.23B
| $495K | ﹤0.01% |
100,100
-276,160
| -73% | -$1.3M |
|
2055
Alerus Financial
ALRS
$831M
| $494K | ﹤0.01% |
22,283
-906
| -4% | -$17.1K |
|
2056
First Trust Natural Gas ETF
FCG
$647M
| $491K | ﹤0.01% |
20,200
| – | – |
|
2057
ePlus
PLUS
$2.42B
| $489K | ﹤0.01% |
6,105
+1,931
| +46% | +$129K |
|
2058
Health Catalyst
HCAT
$154M
| $487K | ﹤0.01% |
52,083
+10,663
| +26% | +$87.1K |
|
|
RYZ
2059
Ryerson Holding Corp
RYZ
$1.44B
| $487K | ﹤0.01% |
13,899
+2,358
| +20% | +$70.3K |
|
2060
RingCentral
RNG
$4.66B
| $486K | ﹤0.01% |
14,240
-21,803
| -60% | -$651K |
|
2061
Rio Tinto
RIO
$158B
| $485K | ﹤0.01% |
6,539
-42,331
| -87% | -$2.84M |
|
|
MASI
2062
DELISTED
Masimo
MASI
| $484K | ﹤0.01% |
4,132
-6,816
| -62% | -$635K |
|
2063
Victory Capital Holdings
VCTR
$6.19B
| $482K | ﹤0.01% |
13,947
+6,995
| +101% | +$224K |
|
|
DCPH
2064
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $482K | ﹤0.01% |
29,670
+11,057
| +59% | +$141K |
|
2065
Signet Jewelers
SIG
$3.61B
| $481K | ﹤0.01% |
4,484
-5,137
| -53% | -$421K |
|
|
SEM
2066
DELISTED
Select Medical
SEM
| $477K | ﹤0.01% |
37,686
-2,929
| -7% | -$37K |
|
2067
IDT Corp
IDT
$1.64B
| $477K | ﹤0.01% |
14,065
-4,947
| -26% | -$146K |
|
2068
PTC Therapeutics
PTCT
$5.68B
| $475K | ﹤0.01% |
17,286
-13,066
| -43% | -$299K |
|
2069
CALL
Cameco
CCJ
$37.6B
| $474K | ﹤0.01% |
11,000
-74,500
| -87% | -$3.12M |
|
2070
CALL
Las Vegas Sands
LVS
$31.7B
| $474K | ﹤0.01% |
9,600
| – | – |
|
2071
MKS Inc
MKSI
$20.1B
| $473K | ﹤0.01% |
4,590
-3,871
| -46% | -$314K |
|
2072
Enterprise Financial Services Corp
EFSC
$2.4B
| $471K | ﹤0.01% |
10,496
-7,956
| -43% | -$311K |
|
2073
Coursera
COUR
$1.52B
| $470K | ﹤0.01% |
+24,132
| New | +$461K |
|
2074
Meritage Homes
MTH
$4.58B
| $470K | ﹤0.01% |
5,390
+140
| +3% | +$9.65K |
|
|
AIFU
2075
AIFU Inc
AIFU
$206M
| $468K | ﹤0.01% |
179
| – | – |
|
Similar funds
HSBC Holdings's Q4 2023 Portfolio in Review
As of Q4 2023, HSBC Holdings held 2,994 positions worth $115B, up 19% from $96.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
HSBC Holdings deployed $6.98B of net new capital in Q4 2023, opening 295 new positions and adding to 1,230 existing holdings. Its largest new stake was GSK: 2,495,096 shares worth $92.3M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Citigroup, an estimated $103M trimmed.
- HSBC Holdings's largest Q4 2023 buy was GSK: 2,495,096 shares worth $92.3M.
- HSBC Holdings added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $890M increase.
- HSBC Holdings's biggest Q4 2023 reduction was Citigroup, cutting an estimated $103M.
- HSBC Holdings fully exited Activision Blizzard in Q4 2023, selling an estimated $129M.
- HSBC Holdings's ten largest holdings make up 26% of its $115B portfolio in Q4 2023.
- HSBC Holdings opened 295 new positions and closed 291 in Q4 2023.
- HSBC Holdings's portfolio value rose 19% quarter-over-quarter to $115B.
Based on HSBC Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.